Shi Changbin, Zhao Xia, Lagergren Anna, Sigvardsson Mikael, Wang Xiangdong, Andersson Roland
Department of Surgery, Lund University Hospital, Lund, Sweden.
Scand J Gastroenterol. 2006 Apr;41(4):472-80. doi: 10.1080/00365520500318965.
Acute pancreatitis (AP) is an inflammatory disorder that develops a complex cascade of immunological events. The local and systemic immune status and inflammatory response might contribute to the understanding of underlying pathophysiological mechanisms and potential treatment.
Severe AP was induced by intraductal perfusion of 5% sodium taurodeoxycholate in rats. mRNA expression of cytokines and chemokines was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) and NF-kappaB activation was assessed by electrophoretic mobility shift assay in fresh pancreatic acini and circulating monocytes 1, 3, 6 or 9 h after sham operation, induction of AP or N-acetylcysteine (NAC) pretreatment. Flow cytometry was performed on cells obtained from the peripheral blood.
An inverse relationship in pancreatic and circulating monocytic NF-kappaB activation was detected 6 and 9 h after induction of AP. NAC further suppressed monocytic NF-kappaB activation induced by AP as seen 9 h after induction of AP. A marked constitutive increase in the expression of IL-6, CINC and MCP-1 was seen in pancreatic acini, whereas no change in mRNA expression of inflammatory mediators was observed in circulating monocytes 6 h after induction of AP. Flow cytometry further confirmed the altered function of circulating monocytes.
The different immune status and inflammatory response in the pancreas and circulating monocytes improve the understanding of the mechanisms by which systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) develop in severe AP. A potential therapeutic approach could be to restore the functional capacity of the immune system in AP. The use of an NF-kappaB inhibitor, preferentially reaching the local inflammatory foci, could be a potential future way of intervention.
急性胰腺炎(AP)是一种引发复杂免疫事件级联反应的炎症性疾病。局部和全身免疫状态以及炎症反应可能有助于理解潜在的病理生理机制和潜在治疗方法。
通过向大鼠胰管内灌注5%牛磺脱氧胆酸钠诱导重症急性胰腺炎。在假手术、诱导急性胰腺炎或N-乙酰半胱氨酸(NAC)预处理后1、3、6或9小时,采用逆转录聚合酶链反应(RT-PCR)测定新鲜胰腺腺泡和循环单核细胞中细胞因子和趋化因子的mRNA表达,并通过电泳迁移率变动分析评估核因子κB(NF-κB)的激活情况。对从外周血获取的细胞进行流式细胞术检测。
在诱导急性胰腺炎后6小时和9小时,检测到胰腺和循环单核细胞中NF-κB激活呈负相关。如在诱导急性胰腺炎后9小时所见,NAC进一步抑制了由急性胰腺炎诱导的单核细胞NF-κB激活。在胰腺腺泡中,白细胞介素-6(IL-6)、趋化因子CINC和单核细胞趋化蛋白-1(MCP-1)的表达有显著的组成性增加,而在诱导急性胰腺炎后6小时,循环单核细胞中炎症介质的mRNA表达未观察到变化。流式细胞术进一步证实了循环单核细胞功能的改变。
胰腺和循环单核细胞中不同的免疫状态和炎症反应有助于更好地理解重症急性胰腺炎中全身炎症反应综合征(SIRS)和多器官功能障碍综合征(MODS)的发生机制。一种潜在的治疗方法可能是恢复急性胰腺炎中免疫系统的功能能力。使用优先到达局部炎症灶的NF-κB抑制剂可能是未来一种潜在的干预方法。